439 related articles for article (PubMed ID: 31345401)
1. Efficacy of head and neck computed tomography for skeletal muscle mass estimation in patients with head and neck cancer.
Jung AR; Roh JL; Kim JS; Choi SH; Nam SY; Kim SY
Oral Oncol; 2019 Aug; 95():95-99. PubMed ID: 31345401
[TBL] [Abstract][Full Text] [Related]
2. Skeletal muscle mass at C3 may not be a strong predictor for skeletal muscle mass at L3 in sarcopenic patients with head and neck cancer.
Yoon JK; Jang JY; An YS; Lee SJ
PLoS One; 2021; 16(7):e0254844. PubMed ID: 34280248
[TBL] [Abstract][Full Text] [Related]
3. Prognostic value of body composition on recurrence and survival of advanced-stage head and neck cancer.
Jung AR; Roh JL; Kim JS; Kim SB; Choi SH; Nam SY; Kim SY
Eur J Cancer; 2019 Jul; 116():98-106. PubMed ID: 31185387
[TBL] [Abstract][Full Text] [Related]
4. Validation of skeletal muscle mass assessment at the level of the third cervical vertebra in patients with head and neck cancer.
Bril SI; Chargi N; Wendrich AW; Wegner I; Bol GH; Smid EJ; de Jong PA; Devriese LA; de Bree R
Oral Oncol; 2021 Dec; 123():105617. PubMed ID: 34749251
[TBL] [Abstract][Full Text] [Related]
5. Interobserver agreement of skeletal muscle mass measurement on head and neck CT imaging at the level of the third cervical vertebra.
Bril SI; Wendrich AW; Swartz JE; Wegner I; Pameijer F; Smid EJ; Bol GH; Pothen AJ; de Bree R
Eur Arch Otorhinolaryngol; 2019 Apr; 276(4):1175-1182. PubMed ID: 30689037
[TBL] [Abstract][Full Text] [Related]
6. The effectiveness of skeletal muscle evaluation at the third cervical vertebral level for computed tomography-defined sarcopenia assessment in patients with head and neck cancer.
Vangelov B; Bauer J; Moses D; Smee R
Head Neck; 2022 May; 44(5):1047-1056. PubMed ID: 35138008
[TBL] [Abstract][Full Text] [Related]
7. Low skeletal muscle mass as predictor of postoperative complications and decreased overall survival in locally advanced head and neck squamous cell carcinoma: the role of ultrasound of rectus femoris muscle.
Galli A; Colombo M; Carrara G; Lira Luce F; Paesano PL; Giordano L; Bondi S; Tulli M; Mirabile A; De Cobelli F; Bussi M
Eur Arch Otorhinolaryngol; 2020 Dec; 277(12):3489-3502. PubMed ID: 32535862
[TBL] [Abstract][Full Text] [Related]
8. The Impact of Skeletal Muscle Depletion on Head and Neck Squamous Cell Carcinoma.
Nishikawa D; Hanai N; Suzuki H; Koide Y; Beppu S; Hasegawa Y
ORL J Otorhinolaryngol Relat Spec; 2018; 80(1):1-9. PubMed ID: 29393251
[TBL] [Abstract][Full Text] [Related]
9. Feasibility of using head and neck CT imaging to assess skeletal muscle mass in head and neck cancer patients.
Swartz JE; Pothen AJ; Wegner I; Smid EJ; Swart KM; de Bree R; Leenen LP; Grolman W
Oral Oncol; 2016 Nov; 62():28-33. PubMed ID: 27865369
[TBL] [Abstract][Full Text] [Related]
10. Assessing skeletal muscle mass based on the cross-sectional area of muscles at the 12th thoracic vertebra level on computed tomography in patients with oral squamous cell carcinoma.
Matsuyama R; Maeda K; Yamanaka Y; Ishida Y; Kato R; Nonogaki T; Shimizu A; Ueshima J; Kazaoka Y; Hayashi T; Ito K; Furuhashi A; Ono T; Mori N
Oral Oncol; 2021 Feb; 113():105126. PubMed ID: 33388617
[TBL] [Abstract][Full Text] [Related]
11. The use of alternate vertebral levels to L3 in computed tomography scans for skeletal muscle mass evaluation and sarcopenia assessment in patients with cancer: a systematic review.
Vangelov B; Bauer J; Kotevski D; Smee RI
Br J Nutr; 2022 Mar; 127(5):722-735. PubMed ID: 33910664
[TBL] [Abstract][Full Text] [Related]
12. A prediction model for skeletal muscle evaluation and computed tomography-defined sarcopenia diagnosis in a predominantly overweight cohort of patients with head and neck cancer.
Vangelov B; Bauer J; Moses D; Smee R
Eur Arch Otorhinolaryngol; 2023 Jan; 280(1):321-328. PubMed ID: 35835910
[TBL] [Abstract][Full Text] [Related]
13. Prognostic Value of Third Cervical Vertebra Skeletal Muscle Index in Oral Cavity Cancer: A Retrospective Study.
Chang SW; Hsu CM; Tsai YH; Chang GH; Tsai MS; Huang EI; Tsai YT
Laryngoscope; 2021 Jul; 131(7):E2257-E2265. PubMed ID: 33433021
[TBL] [Abstract][Full Text] [Related]
14. Feasibility of assessment of skeletal muscle mass on a single cross-sectional image at the level of the fourth thoracic vertebra.
van Heusden HC; Swartz JE; Chargi N; de Jong PA; van Baal MCPM; Wegner I; de Bree R
Eur J Radiol; 2021 Sep; 142():109879. PubMed ID: 34343845
[TBL] [Abstract][Full Text] [Related]
15. Accurate estimation of skeletal muscle mass by comparison of computed tomographic images of the third lumbar and third cervical vertebrae in Japanese patients with oral squamous cell carcinoma.
Ohashi N; Koike K; Sakai K; Nishiyama K; Sasaki T; Ogi K; Dehari H; Kobayashi N; Miyazaki A
Oral Radiol; 2023 Apr; 39(2):408-417. PubMed ID: 36114388
[TBL] [Abstract][Full Text] [Related]
16. Evaluating the prognosis of oral squamous cell carcinoma patients via L3 skeletal muscle index.
Lu X; Tian Y; Huang J; Li F; Shao T; Huang G; Lv X
Oral Dis; 2023 Apr; 29(3):923-932. PubMed ID: 34773352
[TBL] [Abstract][Full Text] [Related]
17. Low skeletal muscle mass is a predictive factor for chemotherapy dose-limiting toxicity in patients with locally advanced head and neck cancer.
Wendrich AW; Swartz JE; Bril SI; Wegner I; de Graeff A; Smid EJ; de Bree R; Pothen AJ
Oral Oncol; 2017 Aug; 71():26-33. PubMed ID: 28688687
[TBL] [Abstract][Full Text] [Related]
18. The use of the second thoracic vertebral landmark for skeletal muscle assessment and computed tomography-defined sarcopenia evaluation in patients with head and neck cancer.
Vangelov B; Bauer J; Moses D; Smee R
Head Neck; 2023 Apr; 45(4):1006-1016. PubMed ID: 36811256
[TBL] [Abstract][Full Text] [Related]
19. Temporalis muscle thickness as an indicator of sarcopenia predicts progression-free survival in head and neck squamous cell carcinoma.
Lee B; Bae YJ; Jeong WJ; Kim H; Choi BS; Kim JH
Sci Rep; 2021 Oct; 11(1):19717. PubMed ID: 34611230
[TBL] [Abstract][Full Text] [Related]
20. Defining reference values for low skeletal muscle index at the L3 vertebra level based on computed tomography in healthy adults: A multicentre study.
Kong M; Geng N; Zhou Y; Lin N; Song W; Xu M; Li S; Piao Y; Han Z; Guo R; Yang C; Luo N; Wang Z; Jiang M; Wang L; Qiu W; Li J; Shi D; Li R; Cheung EC; Chen Y; Duan Z
Clin Nutr; 2022 Feb; 41(2):396-404. PubMed ID: 34999334
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
